|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 1623 for Ifnar1

Category restricted to Publication (x)

0.079s

Categories

Category: Publication
Type Details Score
Publication
First Author: Fox JM
Year: 2015
Journal: Cell
Title: Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.
Volume: 163
Issue: 5
Pages: 1095-1107
Publication
First Author: Diao Y
Year: 2016
Journal: Arterioscler Thromb Vasc Biol
Title: Effects of Long-Term Type I Interferon on the Arterial Wall and Smooth Muscle Progenitor Cells Differentiation.
Volume: 36
Issue: 2
Pages: 266-73
Publication
First Author: Kavrochorianou N
Year: 2016
Journal: J Leukoc Biol
Title: IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Volume: 99
Issue: 1
Pages: 175-88
Publication
First Author: Kuss SK
Year: 2008
Journal: PLoS Pathog
Title: Multiple host barriers restrict poliovirus trafficking in mice.
Volume: 4
Issue: 6
Pages: e1000082
Publication
First Author: Mrkic B
Year: 1998
Journal: J Virol
Title: Measles virus spread and pathogenesis in genetically modified mice.
Volume: 72
Issue: 9
Pages: 7420-7
Publication
First Author: Pickar A
Year: 2017
Journal: PLoS One
Title: Establishing a small animal model for evaluating protective immunity against mumps virus.
Volume: 12
Issue: 3
Pages: e0174444
Publication
First Author: Alphonse N
Year: 2022
Journal: Cell
Title: A family of conserved bacterial virulence factors dampens interferon responses by blocking calcium signaling.
Volume: 185
Issue: 13
Pages: 2354-2369.e17
Publication
First Author: Bode KA
Year: 2007
Journal: Immunology
Title: Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment.
Volume: 122
Issue: 4
Pages: 596-606
Publication
First Author: Wang Q
Year: 2016
Journal: Sci Transl Med
Title: Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus.
Volume: 8
Issue: 369
Pages: 369ra179
Publication
First Author: Brzoza-Lewis KL
Year: 2012
Journal: Cell Immunol
Title: Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes.
Volume: 273
Issue: 1
Pages: 41-51
Publication
First Author: Lim J
Year: 2024
Journal: iScience
Title: Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment.
Volume: 27
Issue: 9
Pages: 110810
Publication  
First Author: Wang Z
Year: 2023
Journal: Mol Ther Nucleic Acids
Title: Reducing cell intrinsic immunity to mRNA vaccine alters adaptive immune responses in mice.
Volume: 34
Pages: 102045
Publication
First Author: Fehr AR
Year: 2015
Journal: J Virol
Title: The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitis.
Volume: 89
Issue: 3
Pages: 1523-36
Publication
First Author: Hörner C
Year: 2020
Journal: Proc Natl Acad Sci U S A
Title: A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
Volume: 117
Issue: 51
Pages: 32657-32666
Publication
First Author: Buchrieser J
Year: 2019
Journal: Science
Title: IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.
Volume: 365
Issue: 6449
Pages: 176-180
Publication
First Author: Richner JM
Year: 2017
Journal: Cell
Title: Vaccine Mediated Protection Against Zika Virus-Induced Congenital Disease.
Volume: 170
Issue: 2
Pages: 273-283.e12
Publication
First Author: Wang R
Year: 2011
Journal: Glia
Title: Activation of interferon signaling pathways in spinal cord astrocytes from an ALS mouse model.
Volume: 59
Issue: 6
Pages: 946-58
Publication
First Author: Schirmer SH
Year: 2010
Journal: J Biol Chem
Title: Blocking interferon {beta} stimulates vascular smooth muscle cell proliferation and arteriogenesis.
Volume: 285
Issue: 45
Pages: 34677-85
Publication
First Author: Chan CC
Year: 2020
Journal: Nat Commun
Title: Type I interferon sensing unlocks dormant adipocyte inflammatory potential.
Volume: 11
Issue: 1
Pages: 2745
Publication
First Author: Kernbauer E
Year: 2013
Journal: PLoS One
Title: Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes.
Volume: 8
Issue: 6
Pages: e65007
Publication
First Author: Narendra SC
Year: 2014
Journal: J Leukoc Biol
Title: Dendritic cells activated by double-stranded RNA induce arthritis via autocrine type I IFN signaling.
Volume: 95
Issue: 4
Pages: 661-6
Publication  
First Author: Nürnberger C
Year: 2019
Journal: J Virol
Title: A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
Volume: 93
Issue: 3
Publication
First Author: Hutzler S
Year: 2017
Journal: Sci Rep
Title: Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles.
Volume: 7
Issue: 1
Pages: 16892
Publication
First Author: Malczyk AH
Year: 2015
Journal: J Virol
Title: A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Volume: 89
Issue: 22
Pages: 11654-67
Publication
First Author: Detje CN
Year: 2009
Journal: J Immunol
Title: Local type I IFN receptor signaling protects against virus spread within the central nervous system.
Volume: 182
Issue: 4
Pages: 2297-304
Publication
First Author: Bohnet SG
Year: 2004
Journal: Brain Res
Title: Mice deficient in the interferon type I receptor have reduced REM sleep and altered hypothalamic hypocretin, prolactin and 2',5'-oligoadenylate synthetase expression.
Volume: 1027
Issue: 1-2
Pages: 117-25
Publication
First Author: Chen J
Year: 2023
Journal: Cell Mol Immunol
Title: Arsenic trioxide elicits prophylactic and therapeutic immune responses against solid tumors by inducing necroptosis and ferroptosis.
Volume: 20
Issue: 1
Pages: 51-64
Publication
First Author: Wilcox DR
Year: 2015
Journal: Proc Natl Acad Sci U S A
Title: HSV targeting of the host phosphatase PP1α is required for disseminated disease in the neonate and contributes to pathogenesis in the brain.
Volume: 112
Issue: 50
Pages: E6937-44
Publication
First Author: Chen Y
Year: 2012
Journal: PLoS One
Title: Thyroid hormone enhances nitric oxide-mediated bacterial clearance and promotes survival after meningococcal infection.
Volume: 7
Issue: 7
Pages: e41445
Publication
First Author: Yauch LE
Year: 2010
Journal: J Immunol
Title: CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination.
Volume: 185
Issue: 9
Pages: 5405-16
Publication  
First Author: Welsch JC
Year: 2019
Journal: J Virol
Title: Type I Interferon Receptor Signaling Drives Selective Permissiveness of Astrocytes and Microglia to Measles Virus during Brain Infection.
Volume: 93
Issue: 13
Publication  
First Author: Pinto AK
Year: 2021
Journal: Front Immunol
Title: The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease.
Volume: 12
Pages: 717425
Publication
First Author: Wang JH
Year: 2010
Journal: J Immunol
Title: Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.
Volume: 184
Issue: 1
Pages: 442-51
Publication
First Author: Scher G
Year: 2023
Journal: NPJ Vaccines
Title: GP38 as a vaccine target for Crimean-Congo hemorrhagic fever virus.
Volume: 8
Issue: 1
Pages: 73
Publication  
First Author: Manet C
Year: 2020
Journal: J Virol
Title: Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of Oas1b.
Volume: 94
Issue: 3
Publication
First Author: Kurnellas MP
Year: 2014
Journal: J Exp Med
Title: Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease.
Volume: 211
Issue: 9
Pages: 1847-56
Publication
First Author: Bryant-Hudson KM
Year: 2013
Journal: Am J Pathol
Title: HSV-1 targets lymphatic vessels in the eye and draining lymph node of mice leading to edema in the absence of a functional type I interferon response.
Volume: 183
Issue: 4
Pages: 1233-42
Publication
First Author: Harney DJ
Year: 2023
Journal: Cell Rep
Title: Dietary restriction induces a sexually dimorphic type I interferon response in mice with gene-environment interactions.
Volume: 42
Issue: 6
Pages: 112559
Publication
First Author: Rieger T
Year: 2013
Journal: PLoS One
Title: Infection of type I interferon receptor-deficient mice with various old world arenaviruses: a model for studying virulence and host species barriers.
Volume: 8
Issue: 8
Pages: e72290
Publication
First Author: Lin L
Year: 2013
Journal: J Immunol
Title: Type I IFN inhibits innate IL-10 production in macrophages through histone deacetylase 11 by downregulating microRNA-145.
Volume: 191
Issue: 7
Pages: 3896-904
Publication  
First Author: Fujii H
Year: 2022
Journal: Viruses
Title: Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV.
Volume: 14
Issue: 8
Publication
First Author: Rhein BA
Year: 2015
Journal: PLoS Pathog
Title: Interferon-γ Inhibits Ebola Virus Infection.
Volume: 11
Issue: 11
Pages: e1005263
Publication
First Author: Pace L
Year: 2010
Journal: J Immunol
Title: APC activation by IFN-alpha decreases regulatory T cell and enhances Th cell functions.
Volume: 184
Issue: 11
Pages: 5969-79
Publication  
First Author: Spengler JR
Year: 2019
Journal: Antiviral Res
Title: Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.
Volume: 170
Pages: 104573
Publication
First Author: Jarousse N
Year: 2011
Journal: J Immunol
Title: Virally-induced upregulation of heparan sulfate on B cells via the action of type I IFN.
Volume: 187
Issue: 11
Pages: 5540-7
Publication
First Author: Qin Q
Year: 2016
Journal: J Virol
Title: Type I Interferons Regulate the Magnitude and Functionality of Mouse Polyomavirus-Specific CD8 T Cells in a Virus Strain-Dependent Manner.
Volume: 90
Issue: 10
Pages: 5187-99
Publication
First Author: Julik E
Year: 2016
Journal: J Virol
Title: Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Volume: 90
Issue: 11
Pages: 5270-9
Publication
First Author: Fairhurst AM
Year: 2009
Journal: J Immunol
Title: Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.
Volume: 183
Issue: 10
Pages: 6831-8
Publication
First Author: Ren X
Year: 2024
Journal: Nat Commun
Title: A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection.
Volume: 15
Issue: 1
Pages: 7009
Publication  
First Author: Jin YH
Year: 2020
Journal: Cells
Title: Infection and Activation of B Cells by Theiler's Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis.
Volume: 9
Issue: 8
Publication  
First Author: Jaberi E
Year: 2020
Journal: EBioMedicine
Title: Identification of unique and shared mitochondrial DNA mutations in neurodegeneration and cancer by single-cell mitochondrial DNA structural variation sequencing (MitoSV-seq).
Volume: 57
Pages: 102868
Publication
First Author: Bloyet LM
Year: 2016
Journal: J Virol
Title: HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases.
Volume: 90
Issue: 15
Pages: 6642-56
Publication  
First Author: Scholte FEM
Year: 2024
Journal: Virus Res
Title: Evaluation of two inoculation routes of an adenovirus-mediated viral protein inhibitor in a Crimean-Congo hemorrhagic fever mouse model.
Volume: 345
Pages: 199398
Publication
First Author: Li XF
Year: 2018
Journal: Nat Commun
Title: Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone.
Volume: 9
Issue: 1
Pages: 673
Publication
First Author: Dorrington MG
Year: 2021
Journal: PLoS Pathog
Title: Type I IFNs facilitate innate immune control of the opportunistic bacteria Burkholderia cenocepacia in the macrophage cytosol.
Volume: 17
Issue: 3
Pages: e1009395
Publication
First Author: Carrero JA
Year: 2004
Journal: J Exp Med
Title: Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.
Volume: 200
Issue: 4
Pages: 535-40
Publication
First Author: Ohka S
Year: 2007
Journal: J Virol
Title: Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor.
Volume: 81
Issue: 15
Pages: 7902-12
Publication
First Author: Auerbuch V
Year: 2004
Journal: J Exp Med
Title: Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.
Volume: 200
Issue: 4
Pages: 527-33
Publication
First Author: Vanmeerbeek I
Year: 2024
Journal: Sci Adv
Title: Targeting conserved TIM3(+)VISTA(+) tumor-associated macrophages overcomes resistance to cancer immunotherapy.
Volume: 10
Issue: 29
Pages: eadm8660
Publication
First Author: Welch SR
Year: 2023
Journal: Sci Adv
Title: Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.
Volume: 9
Issue: 31
Pages: eadh4057
Publication
First Author: Ireland DD
Year: 2008
Journal: J Virol
Title: Type I interferons are essential in controlling neurotropic coronavirus infection irrespective of functional CD8 T cells.
Volume: 82
Issue: 1
Pages: 300-10
Publication
First Author: Santiago-Raber ML
Year: 2003
Journal: J Exp Med
Title: Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
Volume: 197
Issue: 6
Pages: 777-88
Publication
First Author: Schmid MA
Year: 2014
Journal: PLoS Pathog
Title: Monocyte recruitment to the dermis and differentiation to dendritic cells increases the targets for dengue virus replication.
Volume: 10
Issue: 12
Pages: e1004541
Publication
First Author: Schmid MA
Year: 2016
Journal: PLoS Pathog
Title: Mosquito Saliva Increases Endothelial Permeability in the Skin, Immune Cell Migration, and Dengue Pathogenesis during Antibody-Dependent Enhancement.
Volume: 12
Issue: 6
Pages: e1005676
Publication
First Author: Howell KA
Year: 2017
Journal: Cell Rep
Title: Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus.
Volume: 19
Issue: 2
Pages: 413-424
Publication  
First Author: Nash WT
Year: 2017
Journal: Front Immunol
Title: Murine Cytomegalovirus Disrupts Splenic Dendritic Cell Subsets via Type I Interferon-Dependent and -Independent Mechanisms.
Volume: 8
Pages: 251
Publication
First Author: Reboulet RA
Year: 2010
Journal: J Immunol
Title: Prolonged antigen storage endows merocytic dendritic cells with enhanced capacity to prime anti-tumor responses in tumor-bearing mice.
Volume: 185
Issue: 6
Pages: 3337-47
Publication
First Author: Kernbauer E
Year: 2014
Journal: Nature
Title: An enteric virus can replace the beneficial function of commensal bacteria.
Volume: 516
Issue: 7529
Pages: 94-8
Publication
First Author: Bounds CE
Year: 2015
Journal: PLoS One
Title: Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
Volume: 10
Issue: 9
Pages: e0137786
Publication
First Author: Samuel MA
Year: 2005
Journal: J Virol
Title: Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.
Volume: 79
Issue: 21
Pages: 13350-61
Publication
First Author: Wilcox DR
Year: 2015
Journal: PLoS Pathog
Title: Differential reliance on autophagy for protection from HSV encephalitis between newborns and adults.
Volume: 11
Issue: 1
Pages: e1004580
Publication
First Author: Schmidt H
Year: 2009
Journal: Exp Neurol
Title: Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant.
Volume: 216
Issue: 2
Pages: 306-11
Publication
First Author: Welch SR
Year: 2019
Journal: PLoS Pathog
Title: Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice.
Volume: 15
Issue: 12
Pages: e1008183
Publication
First Author: Staeheli P
Year: 2001
Journal: J Virol
Title: Alpha/beta interferon promotes transcription and inhibits replication of borna disease virus in persistently infected cells.
Volume: 75
Issue: 17
Pages: 8216-23
Publication  
First Author: Scholte FEM
Year: 2019
Journal: mBio
Title: Stable Occupancy of the Crimean-Congo Hemorrhagic Fever Virus-Encoded Deubiquitinase Blocks Viral Infection.
Volume: 10
Issue: 4
Publication
First Author: Kavanagh D
Year: 2016
Journal: Blood
Title: Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature.
Volume: 128
Issue: 24
Pages: 2824-2833
Publication
First Author: Reynaud JM
Year: 2014
Journal: J Virol
Title: Human herpesvirus 6A infection in CD46 transgenic mice: viral persistence in the brain and increased production of proinflammatory chemokines via Toll-like receptor 9.
Volume: 88
Issue: 10
Pages: 5421-36
Publication    
First Author: Wichgers Schreur PJ
Year: 2020
Journal: Elife
Title: Multimeric single-domain antibody complexes protect against bunyavirus infections.
Volume: 9
Publication
First Author: Vasconcellos R
Year: 1999
Journal: Int Immunol
Title: Type I IFN sets the stringency of B cell repertoire selection in the bone marrow.
Volume: 11
Issue: 2
Pages: 279-88
Publication
First Author: Zhao X
Year: 2017
Journal: Cell
Title: Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability.
Volume: 169
Issue: 5
Pages: 891-904.e15
Publication
First Author: Metz SW
Year: 2019
Journal: Nat Commun
Title: Oligomeric state of the ZIKV E protein defines protective immune responses.
Volume: 10
Issue: 1
Pages: 4606
Publication
First Author: Thaker SK
Year: 2019
Journal: Cell Metab
Title: Differential Metabolic Reprogramming by Zika Virus Promotes Cell Death in Human versus Mosquito Cells.
Volume: 29
Issue: 5
Pages: 1206-1216.e4
Publication
First Author: Keeffe JR
Year: 2018
Journal: Cell Rep
Title: A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.
Volume: 25
Issue: 6
Pages: 1385-1394.e7
Publication
First Author: Dang JW
Year: 2019
Journal: Cell Rep
Title: Genome-wide Integrative Analysis of Zika-Virus-Infected Neuronal Stem Cells Reveals Roles for MicroRNAs in Cell Cycle and Stemness.
Volume: 27
Issue: 12
Pages: 3618-3628.e5
Publication  
First Author: Bekkar A
Year: 2022
Journal: Front Cell Infect Microbiol
Title: Dissection of the macrophage response towards infection by the Leishmania-viral endosymbiont duo and dynamics of the type I interferon response.
Volume: 12
Pages: 941888
Publication  
First Author: Martínez LE
Year: 2020
Journal: J Virol
Title: Zika Virus Mucosal Infection Provides Protective Immunity.
Volume: 94
Issue: 9
Publication  
First Author: Welch SR
Year: 2020
Journal: Microorganisms
Title: The Crimean-Congo Hemorrhagic Fever Virus NSm Protein is Dispensable for Growth In Vitro and Disease in Ifnar(-/-) Mice.
Volume: 8
Issue: 5
Publication
First Author: Kang TG
Year: 2022
Journal: Nat Commun
Title: Viral coinfection promotes tuberculosis immunopathogenesis by type I IFN signaling-dependent impediment of Th1 cell pulmonary influx.
Volume: 13
Issue: 1
Pages: 3155
Publication  
First Author: Rong H
Year: 2022
Journal: Front Immunol
Title: Self-Assembling Nanovaccine Confers Complete Protection Against Zika Virus Without Causing Antibody-Dependent Enhancement.
Volume: 13
Pages: 905431
Publication
First Author: Xiao Y
Year: 2021
Journal: Cell
Title: A defective viral genome strategy elicits broad protective immunity against respiratory viruses.
Volume: 184
Issue: 25
Pages: 6037-6051.e14
Publication
First Author: Yoshikawa T
Year: 2021
Journal: PLoS Pathog
Title: A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome.
Volume: 17
Issue: 2
Pages: e1008859
Publication
First Author: Durie IA
Year: 2022
Journal: Nat Commun
Title: Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus.
Volume: 13
Issue: 1
Pages: 7298
Publication  
First Author: Song DH
Year: 2021
Journal: Virology
Title: Development of a blocker of the universal phosphatidylserine- and phosphatidylethanolamine-dependent viral entry pathways.
Volume: 560
Pages: 17-33
Publication
First Author: Main BJ
Year: 2018
Journal: PLoS Negl Trop Dis
Title: Vector competence of Aedes aegypti, Culex tarsalis, and Culex quinquefasciatus from California for Zika virus.
Volume: 12
Issue: 6
Pages: e0006524
Publication
First Author: Qiu H
Year: 2008
Journal: J Immunol
Title: Type I IFNs enhance susceptibility to Chlamydia muridarum lung infection by enhancing apoptosis of local macrophages.
Volume: 181
Issue: 3
Pages: 2092-102
Publication
First Author: Hernáez B
Year: 2018
Journal: Nat Commun
Title: A virus-encoded type I interferon decoy receptor enables evasion of host immunity through cell-surface binding.
Volume: 9
Issue: 1
Pages: 5440
Publication
First Author: Lin Q
Year: 1998
Journal: J Exp Med
Title: Impairment of T and B cell development by treatment with a type I interferon.
Volume: 187
Issue: 1
Pages: 79-87
Publication
First Author: Deng X
Year: 2014
Journal: J Virol
Title: Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness cost of resistance.
Volume: 88
Issue: 20
Pages: 11886-98
Publication
First Author: Wierzbicki IH
Year: 2019
Journal: Cell Rep
Title: Group A Streptococcal S Protein Utilizes Red Blood Cells as Immune Camouflage and Is a Critical Determinant for Immune Evasion.
Volume: 29
Issue: 10
Pages: 2979-2989.e15
Publication  
First Author: Westover JB
Year: 2019
Journal: Pathogens
Title: Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice.
Volume: 8
Issue: 4